CORONA
Start SIP
Invest Now
Start SIP in CORONA
Corona Remedies live price: ₹1631.5. It opened at ₹1,571 vs previous close ₹1,567; intraday high/low: ₹1,699/₹1,570. The 50 DMA stands at ₹1,504.72.
Corona Remedies Performance
- Low
- ₹1,570
- High
- ₹1,699
- 52 Week Low
- ₹1,337
- 52 Week High
- ₹1,699
- Open Price₹1,571
- Previous Close₹1,567
- Volume99,545
- 50 DMA₹1,504.72
- 100 DMA-
- 200 DMA-
Investment Returns
- Over 1 Month -0.24%
- Over 3 Month + 53.63%
- Over 6 Month + 53.63%
- Over 1 Year + 53.63%
Smart Investing Starts Here Start SIP with Corona Remedies for Steady Growth!
Corona Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 9,978
- P/B Ratio
- 14.2
- Average True Range
- 60
- EPS
- 30.17
- Dividend Yield
- 0
- MACD Signal
- 27.62
- RSI
- 60.26
- MFI
- 70.43
Corona Remedies Financials
Corona Remedies Technicals
EMA & SMA
Current Price
₹1,631.50
+
64.1
(4.09%)
- Bearish Moving Average 0
- Bullish Moving Average 11
- 20 Day
- ₹1,570.20
- 50 Day
- ₹1,504.72
- 100 Day
- -
- 200 Day
- -
Resistance and Support
1633.5
- R3 1,826.00
- R2 1,762.50
- R1 1,697.00
- S1 1,568.00
- S2 1,504.50
- S3 1,439.00
Corona Remedies Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-02 | Quarterly Results | |
| 2026-01-02 | Quarterly Results | Inter-alia, to consider and approve the financial results for the period ended September 30, 2025 |
Corona Remedies F&O
About Corona Remedies
- NSE Symbol
- CORONA
- BSE Symbol
- 544644
- Managing Director & CEO
- Mr. Niravkumar Kirtikumar Mehta
- ISIN
- INE02ZQ01018
Similar Stocks to Corona Remedies
Corona Remedies FAQs
Corona Remedies share price is ₹1,631 As on 10 March, 2026 | 22:21
The Market Cap of Corona Remedies is ₹9978.3 Cr As on 10 March, 2026 | 22:21
The P/E ratio of Corona Remedies is As on 10 March, 2026 | 22:21
The PB ratio of Corona Remedies is 14.2 As on 10 March, 2026 | 22:21
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.